factor for cervical cancers. We evaluated the clinical performances of two new real-time PCR
assays for detecting HR HPVs compared to that of the Hybrid Capture 2 test (HC2). A total of
356 cervical swab specimens, which had been examined for cervical cytology, were
assayed by Abbott RealTi me HR and Roche Cobas HPV as well as HC2. Sensitivities and
specificities of these assays were determined based on the criteria that concordant results …